The Weber Light Letter

By Robert Weber, Founder, Weber Medical Systems

From studies to practice: The latest in tPBM and laser therapy for clinicians.

Photobiomodulation | Research | Clinical Practice

Subscribe: The Weber Light Letter

ISLA Conference: San Diego 2026

28th International ISLA Conference March 13th – 15th, 2026 | San Diego Mission Bay Resort

Join us for intensive, hands-on training. This year, we are dedicating our afternoon sessions entirely to the practical application of Interstitial, Intravenous, and Photodynamic Tumor therapies.

Focus on Dr. Michael Weber (ISLA President): If you want to master the physical application of these technologies, do not miss Dr. Weber’s deep-dive sessions and practical workshops throughout the weekend:

• Thursday, March 12th (9:00 am – 1:00 pm): Introductory Course & Workshop – Covering the absolute fundamentals and practical demonstrations of PBM and PDT.
• Friday, March 13th (8:15 am): An Update on the Latest Scientific Findings in PBM and PDT. (Followed by Afternoon Workshop Part 1: IV and Transcranial Applications).
• Saturday, March 14th (8:30 am): Therapeutic Protocols and Clinical Findings in Chronic Infections, Autoimmune Disorders, and Longevity. (Followed by Afternoon Workshop Part 2: Interstitial Applications).
• Sunday, March 15th (8:30 am): Latest Clinical Protocols in Photodynamic Cancer Treatment. (Followed by Afternoon Workshop Part 3: Integrative Oncology).

 

👉 [Register Here for ISLA San Diego 2026]

Podcast Rewind: Breaking Regenerative Limits

10x Stem Cells & "Super-Charged" PRP Guest: Dr. Himanshu Bansal, MD

Link to Episode

Dr. Bansal reveals his breakthrough protocol for activating "Very Small Embryonic-Like" (VSEL) stem cells. By using a specific 5-day IV Laser sequence, his lab recorded a massive 10x increase in these regenerative cells circulating in the blood (from ~100 to ~1,000 per ml).

He also breaks down the critical failure of standard LED devices for PRP activation. His data proves that only a 100mW Diode Laser can effectively trigger the mitochondrial cytochrome pathway in platelets, increasing growth factor synthesis and release by 15-20% prior to injection.

Research Radar: 3 Clinical Breakthroughs

1. Repairing the Blood-Brain Barrier (BBB) Post-Hypoxia A landmark mid-February 2026 study demonstrated that PBM can actively rescue blood-brain barrier dysfunction following acute hypoxic stress.

Researchers established that hypoxia-induced BBB breakdown reduces transendothelial electrical resistance (TEER), an effect that was successfully reversed by applying PBM during the recovery phase. PBM achieves this by attenuating the elevation of von Willebrand factor (vWF) and other thrombo-inflammatory signals, engaging defined molecular pathways to reduce oxidative stress in perivascular glia.

2. Systemic Stem Cell Mobilization via Bone Marrow New research highlights the "distant" systemic effects of thermo-photobiomodulation (TPBM). Local laser irradiation of the tibial bone marrow led to a significant increase in mesenchymal stem cell (MSC) counts not only at the target site but also in distant organs like the spleen.

Clinical trials are already leveraging this mechanism, proving that localized bone marrow PBM can circulate stem cells to distant areas of injury to reduce blood biomarkers for heart muscle damage.

3. Reprogramming Tumor Immunity (TAMs) A major January 2026 review analyzed PBM's ability to target the tumor microenvironment by reprogramming Tumor-Associated Macrophages (TAMs). Utilizing 600–1100 nm wavelengths, PBM successfully transitions pro-tumor M2-polarized macrophages into an anti-tumor M1 phenotype.

This shift increases the expression of interleukin-12 and inducible nitric oxide synthase while reducing immunosuppressive markers like CD206, offering a powerful "drug-free" approach to enhance next-generation precision oncology.

With Light,

Robert Weber

Source & credit: By Robert Weber, Founder, Weber Medical Systems